Changes in the Rate of Leucine-Rich Glioma-Inactivated 1 Seropositivity During the COVID-19 Lockdown

Handel AE., Palace J., Bateman E., Waters P., Irani SR.

This case-control study investigates the positivity rates of the most prevalent neuroglial surface antibodies during the COVID-19 pandemic.

DOI

10.1001/jamaneurol.2022.5346

Type

Journal article

Journal

JAMA Neurology

Publisher

American Medical Association (AMA)

Publication Date

01/04/2023

Volume

80

Pages

419 - 419

Permalink Original publication